Product Name | MF | CAS | Details |
---|
H-EVDPIGHLY-OH | Details |
tert-Butyl 2-(aminomethyl)-3-azabicyclo[3.2.0]heptane-3-carboxylate | 1780552-43-3 | Details |
5-(2-Fluorophenyl)-N-methyl-1H-pyrrole-3-methanamine | C12H13FN2 | 1610043-62-3 | Details |
6-Hydroxytropinone | C8H13NO2 | 5932-53-6 | Details |
Homodestcardin | C32H55N5O7 | 917382-84-4 | Details |
Zanamivir azide methyl ester | C12H18N4O7 | 152178-79-5 | Details |
ATP5I antibody | Details |
Bletilol B | C27H26O7 | 147235-17-4 | Details |
5-(Bromomethyl)-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one | C9H8BrNO2 | 245095-50-5 | Details |
N-?Cyclohexyltetrahydro?-?3-?thiophenamine 1,?1-?dioxide hydrochloride | 482617-60-7 | Details |
4-Bromothiophene-2-carbohydrazide | C5H5BrN2OS | 438219-36-4 | Details |
3-Acetoxy-24-hydroxydammara-20,25-diene | C32H52O3 | 143519-04-4 | Details |
5-Methoxybenzene-1,3-dicarbaldehyde | C9H8O3 | 90560-22-8 | Details |
4-Iodobenzaldehyde | C7H5IO | 15164-44-0 | Details |
o-Acetyl silodosin | C27H34F3N3O5 | 160970-86-5 | Details |
Rhein | C15H8O6 | 478-43-3 | Details |
Mad2L1 Antibody | Details |
4-[N-Methyl-1-(pyridin-4-yl)formamido]butanoic acid | C11H14N2O3 | 1152556-15-4 | Details |
1,3,3-Trimethoxypropene | C6H12O3 | 17576-35-1 | Details |
4-Fluorophenoxyacetic acid | C8H7FO3 | 405-79-8 | Details |
(1R) -1- [(2S, 3R,4S) -4-(Acetylamino)methyl-3- hydroxy- 1- azetidinyl] -1, 2- ethanediol | Details |
Methyl N-(2-amino-1,2-dicyanoeth-1-en-1-yl)methanecarboximidate | C6H6N4O | 123060-28-6 | Details |
3'-Azido-3'-deoxycytidine | C9H12N6O4 | 70580-87-9 | Details |
GREM2 antibody | Details |
allo-Isopteropodine | C21H24N2O4 | 5171-37-9 | Details |
2-Bromo-5-fluoro-4-hydroxypyridine | C5H3BrFNO | 1196152-88-1 | Details |
1-(2-Bromoethyl)-4-nitro-1H-pyrazole hydrobromide | C5H7Br2N3O2 | 1354954-24-7 | Details |
CNTROB antibody | Details |
2-Chloro-1-[4-(pyrrolidine-1-carbonyl)piperidin-1-yl]ethan-1-one | C12H19ClN2O2 | 1311313-62-8 | Details |
Pentoxifylline | C13H18N4O3 | 6493-05-6 | Details |
Sodium 2-(4-propoxypyrimidin-2-yl)acetate | C9H13N2NaO3 | 1955523-92-8 | Details |
2-Amino-3-(5-chloro-1,3-thiazol-4-yl)propanoic acid dihydrochloride | 2287261-22-5 | Details |
1H-Indole-3-carbothioic acid amide | C9H8N2S | 59108-90-6 | Details |
Rhaponticin 6'-o-gallate | C28H28O13 | 94356-23-7 | Details |
1-Lauroyl-2-Hydroxy-sn-Glycero-3-Phosphatidylcholine | C20H42NO7P | 20559-18-6 | Details |
5-(4-Methoxyphenyl)-4-[3-(trifluoromethyl)phenyl]-4H-1,2,4-triazole-3-thiol | C16H12F3N3OS | 216501-13-2 | Details |
TYMS Blocking Peptide | Details |
2,2-Dimethyl-1-(4-methylphenyl)propan-1-amine | C12H19N | 854181-05-8 | Details |
8-boc-8-azabicyclo[3.2.1]octane-2-carboxylic acid | C13H21NO4 | 1366053-52-2 | Details |
4(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-one | C15H19BO3 | 1221239-08-2 | Details |
3-Methylpyrrolidine-3-carboxylic acid hydrochloride | C6H12ClNO2 | 1222503-25-4 | Details |
3-(4-tert-Butylphenoxy)propanoic acid | C13H18O3 | 23067-72-3 | Details |
Ethyl 5-(2,4-difluorophenyl)-1,2-oxazole-3-carboxylate | C12H9F2NO3 | 934188-80-4 | Details |
Lerdelimumab | 285985-06-0 | Details |
(5-Methyl-[1,3,4]oxadiazol-2-ylsulfanyl)-acetic acid | C5H6N2O3S | 842965-64-4 | Details |
Methyl 1-bromocyclohexanecarboxylate | C8H13BrO2 | 3196-23-4 | Details |
3-Amino-1-(cyclobutylmethyl)thiourea | C6H13N3S | 1095592-96-3 | Details |
3-Chloro-N-hydroxypropanamide | C3H6ClNO2 | 59617-25-3 | Details |
2-{4-[(tert-Butoxy)carbonyl]-1,1-dioxo-1λ?-thiomorpholin-3-yl}acetic acid | C11H19NO6S | 1542480-23-8 | Details |
N-Ethylpyridin-4-amine | C7H10N2 | 35036-85-2 | Details |
2-Iodo-3-methylaniline | C7H8IN | 89938-16-9 | Details |
Biot-GNTKNHPMLMNLLKDNPADQF-OH | Details |
Tagitinin F | C19H24O6 | 59979-57-6 | Details |
6-Nitro-4-oxo-1,4-dihydroquinoline-3-carbonitrile | C10H5N3O3 | 214470-35-6 | Details |
Finasteride | C23H36N2O2 | 98319-26-7 | Details |
Ethyl 3-(trifluoromethyl)-1,2,4-oxadiazole-5-carboxylate | C6H5F3N2O3 | 1245643-72-4 | Details |
SLC37A1 antibody | Details |
Methyl 8-aminooctanoate hydrochloride | C9H20ClNO2 | 77420-98-5 | Details |
2-(4-Hydroxy-phenyl)-benzothiazole-6-carboxylic acid | C14H9NO3S | 149143-57-7 | Details |
5-indol-3-yl-3-(4-(isopropyl)phenyl)-1H,4H,5H-1,2-diazin-6-one | C21H21N3O | 1019858-00-4 | Details |
4-Methoxy-6-methylpyridine-3-carbaldehyde | C8H9NO2 | 1256823-25-2 | Details |
4-Amino-1-ethyl-N,N-dimethyl-1H-pyrazole-5-carboxamide | C8H14N4O | 1004643-40-6 | Details |
3-(2-Hydroxyethyl)benzeneboronic acid | C8H11BO3 | 647853-32-5 | Details |
N-(2,3-Dimethylphenyl)urea | C9H12N2O | 13114-75-5 | Details |
6-(Azepan-1-yl)pyridine-3-carboxylic acid hydrochloride | C12H17ClN2O2 | 1258640-80-0 | Details |
Methyl 2-(2-Bromothiophen-3-Yl)acetate | C7H7BrO2S | 683251-61-8 | Details |
SLC1A5 Blocking Peptide | Details |
3-[(1,3-Dioxo-2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)amino]benzoic acid | C15H14N2O4 | 1803593-41-0 | Details |
4-(Chloromethyl)-2-(2,6-dichlorophenyl)-1,3-thiazole | C10H6Cl3NS | 90877-03-5 | Details |
({3,5-Dimethyl-4-[(4-methylphenyl)methoxy]phenyl}methyl)(methyl)amine hydrochloride | C18H24ClNO | 1311318-32-7 | Details |
CLPT1 antibody | Details |
UGT1A4 Blocking Peptide | Details |
Lexibulin dihydrochloride | C24H31ClN6O2 | 917111-49-0 | Details |
1-(4-Fluorophenyl)-3-methyl-6-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C17H16FN3O2 | 1018164-74-3 | Details |
6-Chloro-4-methyl-benzothiazol-2-ylamine | C8H7ClN2S | 38338-21-5 | Details |
PP2447 antibody | Details |
(2-Aminomethyl-pyridin-4-yl)-carbamic acid tert-butyl ester | C11H17N3O2 | 887579-50-2 | Details |
(2R,4R)-2-[L-Xylo-tetrahydroxybut-1-yl]-1,3-thiazolidine-4-carboxylic acid | C8H15NO6S | 115184-30-0 | Details |
Ethyl 2-(2-bromo-4-formyl-6-methoxyphenoxy)propanoate | C13H15BrO5 | 695174-82-4 | Details |
4,5,6,7-Tetrahydro-1H-1,2,3-benzotriazol-5-amine hydrochloride | C6H11ClN4 | 2247102-48-1 | Details |
Ethyl 4-amino-1-methyl-1H-pyrazole-3-carboxylate hydrochloride | C7H12ClN3O2 | 1431964-15-6 | Details |
2,3,5-Tri-O-benzoyl-2- C- methyl- D- arabinonic acid gamma-lactone | Details |
Ketamine-HRP Protein | Details |
6-(Iodomethyl)-2,5-dioxaspiro[3.4]octane | C7H11IO2 | 2104511-57-9 | Details |
3-Bromo-6-chloro-1-benzofuran | C8H4BrClO | 36739-97-6 | Details |
Epcoritamab | 2134641-34-0 | Details |
3-Phenyl-2-azaspiro[3.4]oct-6-en-1-one | C13H13NO | 1909309-95-0 | Details |
Dimethyl[(pyridin-3-yl)imino]-λ?-sulfanone | C7H10N2OS | 1621962-58-0 | Details |
2-Chloro-3-fluoropyridin-4-amine hydrochloride | C5H5Cl2FN2 | 1955554-02-5 | Details |
1-[4-Ethoxy-3-(morpholin-4-ylmethyl)phenyl]ethan-1-one | C15H21NO3 | 763916-51-4 | Details |
2-(N-Methyl-2-aminobenzamido)benzoic acid | C15H14N2O3 | 83432-93-3 | Details |
5-(2-methyl(8-quinolyloxy))-2-nitrobenzenecarbonitrile | C17H11N3O3 | 1024068-66-3 | Details |
2-(3-Fluorophenyl)-N-methoxy-N-methylacetamide | C10H12FNO2 | 946402-22-8 | Details |
PLAT Blocking Peptide | Details |
Purified Mouse anti- KLH Monoclonal | Details |
2-(4-Ethylphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid | C13H13NO2S | 343322-60-1 | Details |
Hepatitis B Virus Receptor Binding Fragment | C140H185N35O42 | Details |
H-YQSSPAKPDSSFYK^-OH | Details |
2,4-Dimethyloxane-4-carboxylic acid | C8H14O3 | 2060044-77-9 | Details |
Ethyl 2-(3-bromo-5-nitropyridin-4-yl)acetate | C9H9BrN2O4 | 1363382-04-0 | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |